Israel Englander Kezar Life Sciences, Inc. Transaction History

Millennium Management LLC

$207 Billion
Q2 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Kezar Life Sciences, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 628,514 shares of KZR stock, worth $4.67 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

628,514

Previous 816,973 23.07%

Holding current value

$4.67 Million

Previous $735,000 48.71%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$0.6 - $0.92 $113,075 - $173,382	-188,459 Reduced 23.07%	628,514 $377,000
Q1 2024 May 15, 2024	SELL	$0.8 - $1.05 $1.69 Million - $2.22 Million	-2,110,590 Reduced 72.09%	816,973 $735,000
Q4 2023 Feb 14, 2024	SELL	$0.72 - $1.15 $585,753 - $935,577	-813,546 Reduced 21.75%	2,927,563 $2.78 Million
Q2 2023 Aug 14, 2023	BUY	$2.31 - $3.06 $2.78 Million - $3.68 Million	1,204,006 Added 47.46%	3,741,109 $9.17 Million
Q1 2023 May 15, 2023	SELL	$3.13 - $7.31 $1.12 Million - $2.63 Million	-359,392 Reduced 12.41%	2,537,103 $7.94 Million
Q4 2022 Feb 14, 2023	SELL	$6.39 - $8.8 $420,289 - $578,802	-65,773 Reduced 2.22%	2,896,495 $20.4 Million
Q3 2022 Nov 14, 2022	BUY	$7.99 - $10.75 $1.7 Million - $2.29 Million	213,322 Added 7.76%	2,962,268 $25.5 Million
Q2 2022 Aug 15, 2022	BUY	$4.58 - $17.13 $8.37 Million - $31.3 Million	1,826,884 Added 198.13%	2,748,946 $22.7 Million
Q1 2022 May 16, 2022	BUY	$12.3 - $18.33 $6.54 Million - $9.74 Million	531,420 Added 136.04%	922,062 $15.3 Million
Q4 2021 Feb 14, 2022	BUY	$7.44 - $16.72 $2.81 Million - $6.31 Million	377,366 Added 2842.47%	390,642 $6.53 Million
Q3 2021 Nov 15, 2021	SELL	$4.85 - $9.73 $3.82 Million - $7.67 Million	-788,085 Reduced 98.34%	13,276 $115,000
Q2 2021 Aug 16, 2021	BUY	$4.93 - $6.46 $103,919 - $136,170	21,079 Added 2.7%	801,361 $4.35 Million
Q1 2021 May 17, 2021	SELL	$5.24 - $6.99 $764,379 - $1.02 Million	-145,874 Reduced 15.75%	780,282 $4.65 Million
Q4 2020 Feb 16, 2021	BUY	$4.77 - $6.58 $1.31 Million - $1.81 Million	275,027 Added 42.24%	926,156 $4.84 Million
Q3 2020 Nov 16, 2020	SELL	$4.36 - $5.5 $905,776 - $1.14 Million	-207,747 Reduced 24.19%	651,129 $3.15 Million
Q2 2020 Aug 14, 2020	BUY	$3.6 - $7.75 $2.62 Million - $5.64 Million	727,187 Added 552.2%	858,876 $4.45 Million
Q1 2020 May 14, 2020	BUY	$2.77 - $5.75 $301,035 - $624,892	108,677 Added 472.26%	131,689 $574,000
Q4 2019 Feb 14, 2020	BUY	$2.5 - $4.26 $19,890 - $33,892	7,956 Added 52.84%	23,012 $92,000
Q3 2019 Nov 14, 2019	SELL	$3.0 - $7.58 $141,483 - $357,480	-47,161 Reduced 75.8%	15,056 $49,000
Q2 2019 Aug 15, 2019	SELL	$7.09 - $21.9 $1.12 Million - $3.45 Million	-157,418 Reduced 71.67%	62,217 $480,000
Q2 2019 Aug 14, 2019	BUY	$7.09 - $21.9 $1.56 Million - $4.81 Million	219,635 New	219,635 $39.9 Million
Q4 2018 Feb 14, 2019	SELL	$20.21 - $32.9 $1.1 Million - $1.8 Million	-54,628 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$15.5 - $21.41 $318,060 - $439,333	-20,520 Reduced 27.31%	54,628 $1.17 Million
Q2 2018 Aug 14, 2018	BUY	$17.15 - $17.79 $1.29 Million - $1.34 Million	75,148 New	75,148 $1.3 Million

Others Institutions Holding KZR

# of Institutions

Shares Held

39.6M

Call Options Held

3.2K

Put Options Held

700

View Full List

About Kezar Life Sciences, Inc.

Ticker KZR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,369,504
Market Cap $508M
Description
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...

More about KZR

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account